IHAM
MIRM icon

Integral Health Asset Management’s Mirum Pharmaceuticals MIRM Stock Holding History

Integral Health Asset Management’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-50,000
Closed -$1.05M – 83
2022
Q3 		$1.05M Sell
50,000
-127,427
-72% -$3.07M 0.2% 63
2022
Q2 		$3.45M Buy
177,427
+37,427
+27% +$883K 0.71% 45
2022
Q1 		$3.08M Buy
140,000
+40,000
+40% +$816K 0.8% 44
2021
Q4 		$1.59M Buy
+100,000
New +$1.56M 0.44% 59

Other funds holding MIRM

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
RVM
RiverVest Venture Management St. Louis, Missouri $6.84M AUM 7.71% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Integral Health Asset Management's MIRM Position: Q4 2022 in Review

Integral Health Asset Management sold out of Mirum Pharmaceuticals (MIRM) in Q4 2022, closing a stake of 50,000 shares — an estimated $1.05M sold.

Integral Health Asset Management first reported a position in MIRM in Q4 2021 and held it in 4 quarters. The position peaked at $3.45M in Q2 2022. 104 funds tracked by Wall St. Rank hold MIRM as of Q4 2022.

  • Integral Health Asset Management reported no remaining Mirum Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
  • Integral Health Asset Management sold 50,000 Mirum Pharmaceuticals shares in Q4 2022, an estimated $1.05M.
  • Integral Health Asset Management first reported a position in Mirum Pharmaceuticals in Q4 2021 and held it in 4 quarters.
  • Integral Health Asset Management's Mirum Pharmaceuticals position peaked at $3.45M in Q2 2022.
  • 104 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q4 2022.

Based on Integral Health Asset Management's 13F filing for Q4 2022, filed 13 Feb 2023.